27 results match your criteria: "Augsburg Medical Center[Affiliation]"
Consequences of a combined administration of different doses of aprotinin and autologous blood transfusions for coagulation and fluid replacement in cardiac surgery.
J Cardiovasc Surg (Torino)
December 1994
Department of Cardiovascular Surgery, Augsburg Medical Center, Germany.
Efficacy of aprotinin in different doses and autologous blood transfusions in cardiac surgery.
Cardiovasc Surg
December 1994
Department for Cardiovascular Surgery, Augsburg Medical Center/Zentralklinikum Augsburg, Germany.
A study was undertaken to compare the two doses of aprotinin and the amount of autologous blood transfused in order to determine the optimal dose of this inhibitor for use in cardiac surgery. A total of 120 patients undergoing elective cardiac surgery from November 1990 to April 1992 took part in this randomized double-blind study. Two groups of 60 patients were treated.
View Article and Find Full Text PDF